手术加抗痨治疗结核性肛瘘的临床分析  

Clinical Analysis of Surgery and Anti-tuberculosis Treatment of Tuberculous Anal Fistula

作　　者：田金峰 

机构地区：[1]山东省临沂市沂水县结核病防治所,山东临沂276400

出　　处：《中国医药指南》2016年第17期17-18,共2页Guide of China Medicine

摘　　要：目的探讨手术加抗痨治疗结核性肛瘘临床疗效,为临床治疗结核性肛瘘提供参考。方法 125例结核性肛瘘患者,按照随机数字法分为实验组和对照组,其中实验组63例,对照组62例。对照组采取手术加一般抗炎药物治疗,实验组则采取手术加抗痨治疗。结果实验组痊愈59例,总有效率为98.41%,显著优于对照在88.71%的总有效率(P<0.05)。两组患者完成相应的治疗后均随访1年,实验组59例痊愈患者均未复发,复发率为0,对照组48例痊愈患者有11例复发,复发率为22.92%。结论手术加抗痨治疗结核性肛瘘能够有效的提高治疗效果,提高患者的生活质量。Objective To explore the clinical effect of surgery and anti-tuberculosis treatment of tuberculous anal fistula. Methods 125 cases of tuberculous anal fistula patients were randomly divided into experimental group with 63 cases and control group with 62 cases. Control group received ordinary surgery and anti-inflammatory medication treatment, while experimental group received surgery and anti-tuberculosis treatment. Results In experimental group 59 cases were cured, the total effective rate was 98.41%, significantly better than control group（88.71%）（P〈0.05）. Both groups were followed up for one year, patients in the experimental group had a recurrence rate of 0 in 59 cured cases, the control group had a recurrence rate of 22.92%. Conclusion Surgery plus anti-tuberculosis treatment for tuberculous anal fistula can effectively improve the therapeutic effect, and improve the quality of life of patients.

关 键 词：手术 抗痨 结核性肛瘘 临床分析 

分 类 号：R52[医药卫生—内科学] R657.16[医药卫生—临床医学]